It induces growth arrest via the JAK/STAT signaling pathway after its receptor interaction in the cell membrane, in both in vitro and in vivo models of several cancer cell lines such as melanoma, breast, lung, prostate, and pancreas [43,88,89]. Here, SOAT1 is linked to cancer.